Company intelligence / Profile preview

Triangle Biotechnology

Chapel Hill, North Carolina, United Statestrianglebiotech.com ↗

Ownership: Private
Development stage: Other

Overview

Triangle Biotechnology develops and commercializes innovative acoustic-based sample preparation systems designed to accelerate life science research. Their technologies enable efficient DNA shearing for next-generation sequencing, chromatin shearing for ChIP/ChIP-seq assays, cell lysis protocols, and protein extraction. The company's focus is on simplifying complex laboratory workflows with high-quality, high-throughput devices that improve reproducibility and efficiency in molecular biology applications. There are no clinical results as they do not develop therapeutics.

Modalities: DeviceSample preparation technology (for DNA, chromatin, protein extraction)
Industry: Non-Drug Biotech

Partnerships

University of Arizona inventors involved in founding/IP development

Beyond the preview

Go deeper on Triangle Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triangle Biotechnology.

Explore the full profile